{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:13:08Z","timestamp":1789884788858,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejpb.2013.01.015","type":"journal-article","created":{"date-parts":[[2013,2,16]],"date-time":"2013-02-16T03:15:36Z","timestamp":1360984536000},"page":"599-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro"],"prefix":"10.1016","volume":"84","author":[{"family":"Lusiana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel C.","family":"M\u00fcller-Goymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2013.01.015_b0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","article-title":"New therapeutic options for onychomycosis","volume":"13","author":"Gupta","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejpb.2013.01.015_b0010","doi-asserted-by":"crossref","unstructured":"R.J. Hay, The future of onychomycosis therapy may involve a combination of approaches, Br. J. Dermatol. 145(Suppl.) (2001) 3\u20138.","DOI":"10.1046\/j.1365-2133.2001.00043.x"},{"key":"10.1016\/j.ejpb.2013.01.015_b0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/17425247.2010.525230","article-title":"Topical delivery of antifungal agents","volume":"7","author":"Kaur","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2013.01.015_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/13693780310001656803","article-title":"Antifungal drug response in an in vitro model of dermatophyte nail infection","volume":"42","author":"Osborne","year":"2004","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0019-5154.43216","article-title":"Comparison of the activities of four antifungal agents in an in vitro model of dermatophyte nail infection","volume":"53","author":"Nowrozi","year":"2008","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/13693780802577892","article-title":"Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection","volume":"47","author":"Schaller","year":"2009","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.micinf.2007.07.005","article-title":"cDNA representational difference analysis used in the identification of genes expressed by Trichophyton rubrum during contact with keratin","volume":"9","author":"Baeza","year":"2007","journal-title":"Microb. Infect."},{"key":"10.1016\/j.ejpb.2013.01.015_b0040","unstructured":"J. Lenn, W. Chern, R. Buchta, B. Hunt, M. Larm, M. Brown, R. Turner, E. Hsia, H. Hofland, A Multi-model Approach for the Evaluation of Topical Antifungal Agents and Formulations for the Treatment of Onychomycosis, Focus on Fungal Infections 17: 2007 March 7\u20139, San Diego, CA, US. <http:\/\/www.medpharm.co.uk\/uploads\/media\/2007FocusAntifungal_posterl_03.pdf>."},{"key":"10.1016\/j.ejpb.2013.01.015_b0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1211\/jpp.62.06.0009","article-title":"Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents","volume":"62","author":"Traynor","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejpb.2011.01.022","article-title":"Keratin film made of human hair as a nail plate model for studying drug permeation","volume":"78","author":"Lusiana","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2013.01.015_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.2011.10303.x","article-title":"Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation","volume":"165","author":"Monti","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clindermatol.2009.12.005","article-title":"Epidemiology of superficial fungal infections","volume":"28","author":"Ameen","year":"2010","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1099\/jmm.0.46542-0","article-title":"Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)","volume":"56","author":"da Silva Barros","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0070","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/JCM.43.4.1917-1920.2005","article-title":"Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum","volume":"43","author":"Santos","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0075","unstructured":"Lusiana, In vitro Evaluation of Poloxamer 407-based Formulations for Topical Antifungal Administration of Terbinafine HCl and Assessment of Keratin Film from Human Hair as a Nail Plate Model, Ph.D. Thesis, Technische Universit\u00e4t Braunschweig, Germany, 2012. <http:\/\/www.digibib.tu-bs.de\/?docid=000430>."},{"key":"10.1016\/j.ejpb.2013.01.015_b0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1208\/s12249-011-9611-4","article-title":"Preparation, characterization, and in vitro permeation study of terbinafine hcl in poloxamer 407-based thermogelling formulation for topical application","volume":"12","author":"Lusiana","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2013.01.015_b0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1248\/bpb.25.569","article-title":"A rapid extraction procedure of human hair proteins and identification of phosphorylated species","volume":"25","author":"Nakamura","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2013.01.015_b0090","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1016\/j.biomaterials.2009.08.051","article-title":"Films based on human hair keratin as substrates for cell culture and tissue engineering","volume":"30","author":"Reichl","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2013.01.015_b0095","unstructured":"DSMZ (German Collection of Microorganisms and Cell Cultures Braunschweig, Germany), Personal Communication (2010)."},{"key":"10.1016\/j.ejpb.2013.01.015_b0100","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0190-9622(99)70392-0","article-title":"Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method","volume":"40","author":"Norris","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0105","unstructured":"D. Lebo, C. Lee, J. Lee, F. Cupo, J. Ryoo, Development of skin permeation study method for terbinafine HCl, in: Proceedings of the AAPS Annual Meeting and Exposition; 2005 November 5\u201310; Nashville, TN, US. <http:\/\/abstracts.aapspharmaceutica.com\/ExpoAAPS05\/CC\/forms\/attendee\/index.aspx?content=sessionInfo&sessionId=1804>."},{"key":"10.1016\/j.ejpb.2013.01.015_b0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000324055","article-title":"An assessment of the human nail plate pH","volume":"24","author":"Murdan","year":"2011","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1099\/jmm.0.46474-0","article-title":"Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis","volume":"55","author":"Yazdanparast","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/JCM.38.1.341-344.2000","article-title":"Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates","volume":"38","author":"Jessup","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejpb.2013.01.015_b0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10156-002-0192-8","article-title":"Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro","volume":"8","author":"Nakashima","year":"2002","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ejpb.2013.01.015_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.01.015_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1590\/S0037-86822009000300003","article-title":"Comparison of in vitro activity of five antifungal agents against dermatophytes, using the agar dilution and broth microdilution methods","volume":"42","author":"Mota","year":"2009","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ejpb.2013.01.015_b0140","first-page":"604","article-title":"Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails","volume":"61","author":"Neubert","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2013.01.015_b0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0733-8635(03)00025-1","article-title":"The use of topical therapies to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol. Clin."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:30:56Z","timestamp":1760545856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641113000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0939641113000404"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.01.015","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}